Introduction
Among opportunistic diseases in the Russian Federation (RF) registered among HIV-infected patients, more than 90% are infectious pathologies. More than 60% of cases in the structure of the latter, in turn, are tuberculosis, which causes the death of about 50% of patients with HIV infection. At the same time, among the HIV-infected, there is an increase in the number of diagnosed mycobacteriosis on the background of stage III and IV HIV infection. However, mycobacterial infection can accelerate the progression of AIDS by reducing the number of CD4 + lymphocytes [Corbett E. et al., 2003] . HIVinfected patients often suffer from mycobacteriosis caused by Mycobacterium avium and Mycobacterium intracellulare, which tend to form a complex called Mycobacterium avium complex (MAC). Non-tuberculosis mycobacteria (NTMB) are ubiquitous in the environment and are now considered as saprophytes and conditionally pathogenic bacteria capable of causing a disease clinically very similar to tuberculosis. Two ways of human infection of MAC-related NTMB have been proven: airborne (through the respiratory system) and through food and water (through the gastrointestinal tract). One of the objectives of this study is to determine the level of CD4 + lymphocytes among HIV-infected patients in the Republic of Mari El (RME), which promoted mycobacteriosis development, since the literature data determine the levels of this clinical and laboratory indicator, in which the incidence of mycobacteriosis among patients with HIV infection increases, as less than 100 cells/μL (N.V. Fomenkova, 2011) or less than 200 cells/μl (N.R. Mikhailova, 2015) [1, 2, 3, 4, 5, 6] . In Western countries, the problem of NTMB has been well studied, since mycobacteriosis is quite often diagnosed in HIV-infected patients at the stage of AIDS. The real picture of the prevalence of mycobacteriosis in the Russian Federation remains unknown. The problem of diagnosing the disease caused by NTMB remains unresolved due to incomplete bacteriological examination of HIVinfected patients for this pathogen because of the lack of standards for diagnosis and treatment of mycobacteriosis. Mycobacteriosis-causing NTMBs cannot be treated with anti-tuberculosis drugs despite their similar clinical and radiologic patterns with tuberculosis, which affects the results of treatment of this, often misdiagnosed, opportunistic disease [7, 8, 9, 10, 11] . At the same time, there is a problem of correct interpretation of bacteriological studies on mycobacteriosis. Bacteriological laboratory tests of NTMB culture bear a probability that the received positive result can indicate both its relation to pathological process, and possible contamination of a sample from an environment or an asymptomatic colonization of organs and systems of the patient. This issue requires a comprehensive solution on the part of providing an anti-epidemic regime in Copyright © 2018 Helix ISSN 2319 -5592 (Online) bacteriological laboratories, including during microbiological monitoring of laboratory facilities [12] . The only bacteriological laboratory in the RME involved in the laboratory diagnosis of mycobacteriosis is located on the basis of the Republican tuberculosis dispensary of the RME. The doctors in this bacteriological laboratory have been working in this direction since 1994, which allows correctly prescribing therapy to patients.
Methods
Laboratory bacteriological analysis of biological fluids of patients for M.tuberculosis used the method of cultivation on solid nutrient media LevenshteinJensen and Finn II and on the liquid medium Middlebrook 7N9 using the VASTES MGIT 960 instrument. A primary identification was performed after growing culture. In the case of NTMB identification, PCR was carried out, followed by hybridization of the amplification products on DNA strips (GenoTypeCM and GenoTypeAS kits, HAIN Lifescience, Germany).
Medical cards of patients with HIV infection of the Republican Center for the Prevention and Control of AIDS and Infectious Diseases of the RME, forms of federal statistical observation (No. 33 "Information on TB patients", No.61 "Information on contingents of patients with HIV infection") were reviewed; statistical and graphoanalytical methods were used.
Results
In the period of 2007-2016, the growth of the incidence of HIV infection was registered on the territory of the RME (2007: 8.9 per 100,000 of people, 2016: 19.6 per 100,000 of people, the equation of approximation is y=x+75.71, the reliability of R 2 =0.8894). During this period, there was a statistically significant decrease in the incidence of tuberculosis in the republic from 76.6 per 100,000 of people in 2007 to 48. 4 per 100,000 of people in 2016 (the approximation equation is y=-3.8618x+87.26, R 2 =0.8894). The average annual incidence of tuberculosis is 5.1 times higher than that of HIV infection (Fig.1) . The expediency of prescribing chemoprophylaxis of tuberculosis among patients with HIV infection can be judged subject to such clinico-diagnostic indicator as the level of CD4 + lymphocytes. In the RME, tuberculosis among this cohort is recorded at the level of CD4 + lymphocytes less than 350 cells/μl. During the entire period of registration of HIV infection in the territory of the RME (the first cases of HIV infection were registered in the RME since 1990), 3 cases of mycobacteriosis associated with HIV infection were detected. Thus, in order to establish the level of CD4 + lymphocytes, when mycobacteriosis develops in HIV-infected patients, a large sample and number of registered cases, respectively, are required. In the second case, a mixed infection of HIV-associated tuberculosis and mycobacteriosis is observed (Table 1) In 2016, 23 cases of HIV-associated tuberculosis were registered in the territory of the RME. 17 of them are newly diagnosed cases of tuberculosis (including 2 homeless people), 3 -relapsed tuberculosis, and 3 -newcomers to the republic. All newly diagnosed individuals had tuberculosis mycobacteria detected by culture methods; in addition, mycobacteria of tuberculosis were detected microscopically in 15 HIV-infected patients. Among 3 cases of relapses, 2 people did not provide data on primary enrollment in the Republican TB Dispensary of the RME, but 1 person in 1995 was diagnosed with tuberculosis mycobacteria. One HIV-infected person with a tuberculosis relapse in 2011 was diagnosed with a tuberculosis process without isolation of tuberculosis mycobacteria. In all cases of the relapsed disease, no tuberculosis mycobacteria were isolated by culture methods, however, 1 person was detected to have MBT DNA, found by the real-time PCR method. Among the 3 newcomers, the culture of tuberculosis mycobacteria was found in 1 patient. All HIV-infected bacterioviruses were examined for drug resistance (DR) against the main and reserve anti-tuberculosis drugs (Isoniazid, Rifampicin, Streptomycin, Ethambutol, Kanamycin, Capreomycin, Ofloxacin, Prothionamide, paraaminosalicylic acid, Cycloserine). Multiple drug resistance (MDR) to anti-tuberculosis drugs, as well as DR to Isoniazid and Rifampicin was determined by PCR analysis in 1 case of relapse (Table 2) . The vast majority of people with HIV-associated tuberculosis are resistant to main anti-tuberculosis drugs.
Summary
Over the past 10 years, the RME has established an increase in the incidence of HIV infection by 2. + lymphocyte cell count of 399 cells/μl, a case of mixed infection of HIVassociated tuberculosis and atypical mycobacteriosis was established in one HIV-infected patient). In the RME, tuberculosis among HIV-infected patients was recorded at the level of CD4 + lymphocytes less than 350 cells/μl.
